Methylphenidate has long-lasting metaplastic effects in the prefrontal cortex of adolescent rats

Behavioural Brain Research

Volumn 291, Issue , 2015, Pages 112-117

  Burgos, H ^a,b   Cofre C ^a   Hernandez A ^a   Saez Briones P ^a   Agurto, R ^c   Castillo, A ^c   Morales, B ^d   Zeise, M L ^a  

^a Laboratorio de Neurobiología Facultad de Química y Biología FAHU USACH   (Chile)

^b UNIVERSIDAD CENTRAL DE CHILE   (Chile)

^c UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^d UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Long term potentiation; Metaplasticity; Methylphenidate; Prefrontal cortex

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; IN VIVO STUDY; LEARNING; LONG TERM POTENTIATION; MALE; MENTAL PERFORMANCE; METAPLASTICITY; NERVE CELL PLASTICITY; NONHUMAN; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; RADIAL ARM MAZE TEST; RAT; TASK PERFORMANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MAZE TEST; MICROELECTRODE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; METHYLPHENIDATE; MICROELECTRODES; NOOTROPIC AGENTS; PREFRONTAL CORTEX; RATS, SPRAGUE-DAWLEY;

EID: 84930632014     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.05.009     Document Type: Article

References (22)

1. Greenhill L.L., Pliszka S., Dulcan M.K., Bernet W., Arnold V., Beitchman J., et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002, 41:26S-49S.
2. Advokat C., Scheithauer M. Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Front Neurosci 2013, 7:82.
3. Clemow D.B., Walker D.J. The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med 2014, 126:64-81.
4. Marco E.M., Adriani W., Ruocco L.A., Canese R., Sadile A.G., Laviola G. Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure. Neurosci Biobehav Rev 2011, 35:1722-1739.
5. Berridge C.M., Devilbiss D.M. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69:101-111.
6. Zhu N., Weedon J., Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.
7. Kuczenski R., Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 2002, 22:7264-7271.
8. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120.
9. Sarvey J.M., Burgard E.C., Decker G. Long-term potentiation: studies in the hippocampal slice. J Neurosci Methods 1989, 28:109-124.
10. Lovinger D.M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 2010, 58:951-961.
11. Dommett E.J., Henderson E.L., Westwell M.S., Greenfield S.A. Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn Mem 2008, 15:580-586.
12. Urban K.R., Li Y.C., Gao W.J. Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex. Neurobiol Learn Mem 2013, 101:65-74.
13. Schweren L.J.S., de Zeeuw P., Durston S. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2013, 10:1151-1164.
14. Abraham W.C., Bear M.F. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 1996, 19:126-130.
15. Burgos H., Castillo A., Flores O., Puentes G., Morgan C., Gatica A., et al. Effect of modafinil on learning performance and neocortical long-term potentiation in rats. Brain Res Bull 2010, 83:238-244.
16. Swanson J.M., Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 2003, 27:615-621.
17. Devilbiss D.M., Berridge C.W. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 2008, 64:626-635.
18. Haleem D.J., Inam Q.U., Haleem M.A. Effects of clinically relevant doses of methylphenidate on spatial memory, behavioral sensitization and open field habituation: a time related study. Behav Brain Res 2015, 281:208-214.
19. Rostron C.L., Kaplan E., Gaeta V., Nigriello R., Dommett E.J. The effects of methylphenidate on cognitive performance of healthy male rats. Front Neurosci 2013, 7:97.
20. Arias-Cavieres A., Rozas C., Reyes-Parada M., Barrera N., Pancetti F., Loyola S., et al. MDMA (ecstasy) impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats. Neurosci Lett 2010, 469:375-379.
21. Rozas C., Loyola S., Ugarte G., Zeise M.L., Reyes-Parada M., Pancetti F., et al. MDMA acutely applied enhances long-term potentiation in the rat hippocampus involving D1/D5 and 5-HT2A/C receptors through a polysynaptic mechanism. Eur J Neuropsychopharm 2012, 22:584-595.
22. Schwarz R., Reif A., Scholz C.J., Weissflog L., Schmidt B., Lesch K.P., et al. A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients. World J Biol Psychiatry 2015, 16:180-189.